UHS · Universal Health Services Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.50B | - | $4.50B | $4.28B | $4.10B | - | $3.96B | $3.91B | $3.84B | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | $3.99B | - | $3.97B | $3.78B | $3.64B | - | $3.58B | $3.47B | $3.45B | - |
| D&A | $155.43M | - | $155.06M | $152.00M | $148.34M | - | $149.57M | $147.48M | $141.00M | - |
| Operating Income | $502.86M | - | $521.69M | $500.27M | $454.82M | - | $384.17M | $436.40M | $388.76M | - |
| Interest Expense | $37.13M | - | $38.43M | $35.36M | $40.06M | - | $44.66M | $48.90M | $52.83M | - |
| Income Tax | $110.44M | - | $117.78M | $110.77M | $98.80M | - | $75.62M | $87.68M | $70.26M | - |
| Net Income | $348.68M | - | $372.96M | $353.22M | $316.68M | - | $258.71M | $289.15M | $261.83M | - |
| EPS - Basic | $5.71 | - | $5.92 | $5.49 | $4.87 | - | $3.89 | $4.32 | $3.90 | - |
| EPS - Diluted | $5.65 | - | $5.86 | $5.43 | $4.80 | - | $3.80 | $4.26 | $3.82 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $119.03M | $137.80M | $112.89M | $137.59M | $126.75M | $125.98M | $106.08M | $128.79M | $112.09M | $119.44M |
| Accounts Receivable | $2.75B | $2.60B | $2.59B | $2.30B | $2.41B | $2.18B | $2.21B | $2.16B | $2.30B | $2.24B |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | $750.13M | - | - | - | $632.00M | - | - | - | $613.97M |
| Current Assets | $3.50B | $3.41B | $3.26B | $2.99B | $3.08B | $2.82B | $2.80B | $2.74B | $2.87B | $2.81B |
| Total Assets | $15.68B | $15.53B | $15.34B | $14.99B | $14.88B | $14.47B | $14.35B | $14.07B | $14.05B | $13.97B |
| Current Liabilities | $3.24B | $3.24B | $3.16B | $2.32B | $2.33B | $2.21B | $2.01B | $2.15B | $2.08B | $2.01B |
| Long-term Debt | $3.95B | $4.00B | $3.95B | $4.54B | $4.61B | $4.46B | $4.62B | $4.42B | $4.73B | $4.79B |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $7.46B | $7.28B | $7.17B | $7.03B | $6.79B | $6.67B | $6.61B | $6.49B | $6.26B | $6.15B |
| Retained Earnings | - | $7.99B | - | - | - | $7.37B | - | - | - | $6.80B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $401.63M | - | - | - | $360.05M | - | - | - | $396.41M | - |
| Investing Cash Flow | ($197.58M) | - | - | - | ($271.30M) | - | - | - | ($194.64M) | - |
| Financing Cash Flow | ($221.89M) | - | - | - | ($91.42M) | - | - | - | ($208.95M) | - |
| CapEx | $217.16M | - | - | - | $239.03M | - | - | - | $208.54M | - |
| Free Cash Flow | $184.47M | - | - | - | $121.02M | - | - | - | $187.87M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 11.2% | - | 11.6% | 11.7% | 11.1% | - | 9.7% | 11.2% | 10.1% | - |
| EBITDA margin | 14.6% | - | 15.1% | 15.2% | 14.7% | - | 13.5% | 14.9% | 13.8% | - |
| Net margin | 7.8% | - | 8.3% | 8.2% | 7.7% | - | 6.5% | 7.4% | 6.8% | - |
| Free cash flow margin | 4.1% | - | - | - | 3.0% | - | - | - | 4.9% | - |
| FCF / Net income | 0.53 | - | - | - | 0.38 | - | - | - | 0.72 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 24.1% | - | 24.0% | 23.9% | 23.8% | - | 22.6% | 23.3% | 21.2% | - |
| Return on assets | 2.2% | - | 2.4% | 2.4% | 2.1% | - | 1.8% | 2.1% | 1.9% | - |
| Return on equity | 4.7% | - | 5.2% | 5.0% | 4.7% | - | 3.9% | 4.5% | 4.2% | - |
| Return on invested capital | 3.3% | - | 3.6% | 3.3% | 3.0% | - | 2.6% | 3.1% | 2.8% | - |
| Liquidity | ||||||||||
| Current ratio | 1.08 | 1.05 | 1.03 | 1.29 | 1.32 | 1.27 | 1.39 | 1.28 | 1.38 | 1.40 |
| Quick ratio | 1.08 | 1.05 | 1.03 | 1.29 | 1.32 | 1.27 | 1.39 | 1.28 | 1.38 | 1.40 |
| Cash ratio | 0.04 | 0.04 | 0.04 | 0.06 | 0.05 | 0.06 | 0.05 | 0.06 | 0.05 | 0.06 |
| Leverage | ||||||||||
| Debt / Equity | 0.53 | 0.55 | 0.55 | 0.65 | 0.68 | 0.67 | 0.70 | 0.68 | 0.76 | 0.78 |
| Debt / Assets | 0.25 | 0.26 | 0.26 | 0.30 | 0.31 | 0.31 | 0.32 | 0.31 | 0.34 | 0.34 |
| Debt / EBITDA | 6.00 | - | 5.84 | 6.96 | 7.64 | - | 8.65 | 7.56 | 8.94 | - |
| Interest coverage | 13.5x | - | 13.6x | 14.1x | 11.4x | - | 8.6x | 8.9x | 7.4x | - |
| Equity multiplier | 2.10 | 2.13 | 2.14 | 2.13 | 2.19 | 2.17 | 2.17 | 2.17 | 2.24 | 2.27 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.29 | - | 0.29 | 0.29 | 0.28 | - | 0.28 | 0.28 | 0.27 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 223d | - | 210d | 196d | 215d | - | 204d | 201d | 218d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 31.7x | - | 34.9x | 33.4x | 39.1x | - | 60.3x | 43.4x | 47.8x | - |
| P / B | 1.5x | - | 1.8x | 1.7x | 1.8x | - | 2.4x | 1.9x | 2.0x | - |
| P / S | 2.5x | - | 2.9x | 2.7x | 3.0x | - | 3.9x | 3.2x | 3.3x | - |
| EV / EBITDA | 22.6x | - | 24.9x | 24.8x | 28.0x | - | 37.7x | 28.9x | 32.3x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 9.6% | - | 13.4% | 9.6% | 6.7% | - | 11.2% | 10.1% | 10.8% | - |
| Revenue CAGR (3y) | 9.0% | - | 10.5% | 8.8% | 7.6% | - | 7.9% | 6.9% | 8.5% | - |
| Revenue CAGR (5y) | 8.3% | - | 9.1% | 9.4% | 7.7% | - | 7.0% | 6.5% | 6.5% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 10.6% | - | 35.8% | 14.6% | 17.0% | - | 34.6% | 55.8% | 39.5% | - |
| Net income growth (YoY) | 10.1% | - | 44.2% | 22.2% | 20.9% | - | 54.9% | 68.8% | 60.5% | - |
| EPS growth (YoY) | 17.7% | - | 54.2% | 27.5% | 25.7% | - | 58.3% | 76.0% | 67.5% | - |
| EPS CAGR (3y) | 35.3% | - | 32.8% | 35.1% | 33.4% | - | 13.5% | 4.0% | 16.3% | - |
| EPS CAGR (5y) | 18.4% | - | 15.8% | 13.0% | 24.0% | - | 28.1% | 9.9% | 8.2% | - |
| FCF growth (YoY) | 52.4% | - | - | - | -35.6% | - | - | - | 54.0% | - |
| FCF CAGR (5y) | - | - | - | - | -17.6% | - | - | - | -3.2% | - |
| Book value growth (YoY) | 10.0% | 9.1% | 8.5% | 8.4% | 8.5% | 8.4% | 8.9% | 6.5% | 4.1% | 3.9% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$17.42B totalAcute Care Hospital Services$9.93B · 57.0%
Behavioral Health Services$7.43B · 42.6%
State Medicaid Programs$56.00M · 0.3%
All Other Segments$13.42M · 0.1%
Product / service
$12.85B totalManaged Care$3.26B · 25.4%
Health Care$1.91B · 14.9%
Managed Medicare$1.66B · 12.9%
Medicare$1.54B · 12.0%
Medicaid$1.34B · 10.4%
UKRevenue$1.00B · 7.8%
Other Non Patient Revenue$864.33M · 6.7%
Managed Medicaid$685.08M · 5.3%
Other Patient Revenue And Adjustments Net$584.53M · 4.6%
Investment Advice$5.60M · 0.0%
Peer comparison
Same SIC group: Services-General Medical & Surgical Hospitals, NEC
Comparing UNIVERSAL HEALTH SERVICES INC against the 5 most active filers in the same SIC group.
Dividends
$0.60/share trailing 12 months · -25.0% YoY
| Ex-date | Per share |
|---|---|
| Mar 2, 2026 | $0.2000 |
| Dec 1, 2025 | $0.2000 |
| Sep 2, 2025 | $0.2000 |
| Jun 2, 2025 | $0.2000 |
| Mar 3, 2025 | $0.2000 |
| Dec 3, 2024 | $0.2000 |
| Sep 3, 2024 | $0.2000 |
| Jun 3, 2024 | $0.2000 |
| Feb 29, 2024 | $0.2000 |
| Nov 30, 2023 | $0.2000 |
| Aug 31, 2023 | $0.2000 |
| May 31, 2023 | $0.2000 |
| Feb 28, 2023 | $0.2000 |
| Nov 30, 2022 | $0.2000 |
| Aug 31, 2022 | $0.2000 |
| May 31, 2022 | $0.2000 |
| Feb 28, 2022 | $0.2000 |
| Nov 30, 2021 | $0.2000 |
| Aug 31, 2021 | $0.2000 |
| Jun 1, 2021 | $0.2000 |
| Mar 12, 2021 | $0.2000 |
| Feb 28, 2020 | $0.2000 |
| Dec 4, 2019 | $0.2000 |
| Aug 30, 2019 | $0.2000 |